Literature DB >> 2672532

Epidermal growth factor in urine after kidney transplantation in humans.

N Kvist1, E Nexø.   

Abstract

The urinary excretion of epidermal growth factor (EGF) was studied after kidney transplantation in 15 patients. At the final follow-up (between 38 and 173 days after transplantation) the 9 patients with a successful transplantation excreted EGF in the urine, but the concentration was low (0.13-1.1 nmol/l) compared to individuals with two kidneys (1.0-9.8 nmol/l). In all of the patients the urine creatinine increased prior to the increase in urine EGF. Patients who received cyclosporine A as immunosuppressive treatment excreted little or no EGF during the first month, while patients who received prednisone and azathioprine excreted EGF as early as four days after the transplantation. Our results together with earlier published data suggests that urinary EGF originates from the kidney.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672532     DOI: 10.1007/bf00262606

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  12 in total

1.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

2.  Immunocytochemical localization of epidermal growth factor in mouse kidney.

Authors:  E C Salido; L Barajas; J Lechago; N P Laborde; D A Fisher
Journal:  J Histochem Cytochem       Date:  1986-09       Impact factor: 2.479

3.  Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

Authors:  P U Heitz; M Kasper; S van Noorden; J M Polak; H Gregory; A G Pearse
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

4.  Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.

Authors: 
Journal:  Clin Nephrol       Date:  1985-09       Impact factor: 0.975

5.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

6.  Immunohistochemical localization of epidermal growth factor in rat and man.

Authors:  S S Poulsen; E Nexø; P S Olsen; J Hess; P Kirkegaard
Journal:  Histochemistry       Date:  1986

7.  Epidermal growth factor in mouse urine: non-blood origin, and increase by sialoadenectomy and T4 therapy.

Authors:  J Perheentupa; J Lakshmanan; D A Fisher
Journal:  Acta Endocrinol (Copenh)       Date:  1985-03

8.  Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization.

Authors:  G I Bell; N M Fong; M M Stempien; M A Wormsted; D Caput; L L Ku; M S Urdea; L B Rall; R Sanchez-Pescador
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

9.  Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease.

Authors:  A L Mattila; A Pasternack; L Viinikka; J Perheentupa
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

10.  Human salivary epidermal growth factor, haptocorrin and amylase before and after prolonged exercise.

Authors:  E Nexø; M R Hansen; L Konradsen
Journal:  Scand J Clin Lab Invest       Date:  1988-05       Impact factor: 1.713

View more
  1 in total

1.  An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases.

Authors:  N H Chow; T S Tzai; P E Cheng; C J Chang; J S Lin; M J Tang
Journal:  Urol Res       Date:  1994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.